Literature DB >> 9552318

The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.

J Z Li1, G S Rekhi, L L Augsburger, R F Shangraw.   

Abstract

The objective of this study was to examine the influence of intra- and extragranular microcrystalline cellulose (MCC) on drug dissolution from tablets made by high-shear granulation. Granulations were made in a Littleford Model W-10-B (10-liter) mixer and dried in a fluid bed dryer (Niro Inc.). A Plackett-Burman screening design and 2(3) factorial design were employed to study how drug type, MCC (intra- or extra-), filler type (lactose or dicalcium phosphate), disintegrant type (sodium starch glycolate or croscarmellose sodium) and level, proportion of magnesium stearate, and impeller speed affect tablet hardness, disintegration time, and dissolution. Two model drugs were chosen based on their solubility: metoprolol tartrate (solubility > 1000 mg/ml) and hydrochlorothiazide (solubility = 1.05 mg/ml). Tablets were compressed to the same target weight (dose) and similar tablet hardness. In some cases, dissolution testing was also carried out on the loose granules. The intra-extragranular distribution of MCC was found critical to the compactibility and initial dissolution rates from these tablets. Intragranular MCC reduced drug dissolution, the effect being most marked in the case of the slightly soluble hydrochlorothiazide. For formulations containing intragranular MCC, the granulating fluid level on tablet dissolution was also important, since an increase in fluid level resulted in slower drug dissolution from both the loose granules and the tablets compressed from them. Conversely, extragranular MCC tended to increase both dissolution rates and compactibility. It may be concluded that the appropriate distribution of MCC between and within granules may optimize both dissolution and compactibility without changing overall tablet composition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9552318     DOI: 10.3109/10837459609031429

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  4 in total

1.  Dissolution variability: comparison of commercial dosage forms with US Pharmacopeia Lot P Prednisone reference standard tablets--a technical note.

Authors:  Pallavi Nithyanandan; Walter W Hauck; Jimmy Munoz; Gang Deng; William Brown; Ronald G Manning; Samir Wahab
Journal:  AAPS PharmSciTech       Date:  2008-02-08       Impact factor: 3.246

2.  Formulation design of double-layer in the outer shell of dry-coated tablet to modulate lag time and time-controlled dissolution function: studies on micronized ethylcellulose for dosage form design (VII).

Authors:  Shan-Yang Lin; Kung-Hsu Lin; Mei-Jane Li
Journal:  AAPS J       Date:  2004-07-14       Impact factor: 4.009

3.  Evaluation of strain-induced hydrophobicity of pharmaceutical blends and its effect on drug release rate under multiple compression conditions.

Authors:  Kalyana Pingali; Rafael Mendez; Daniel Lewis; Bozena Michniak-Kohn; Alberto Cuitiño; Fernando Muzzio
Journal:  Drug Dev Ind Pharm       Date:  2010-10-13       Impact factor: 3.225

4.  Exploration of Novel Co-processed Multifunctional Diluent for the Development of Tablet Dosage Form.

Authors:  M C Gohel; T M Patel; R K Parikh; P B Parejiya; B S Barot; A Ramkishan
Journal:  Indian J Pharm Sci       Date:  2012-09       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.